These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14574944)

  • 1. [Dominant negative IGF-I receptor ].
    Adachi Y; Min Y; Yamamoto H; Imai K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():500-4. PubMed ID: 14574944
    [No Abstract]   [Full Text] [Related]  

  • 2. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis.
    Lim HJ; Park HY; Ko YG; Lee SH; Cho SY; Lee EJ; Jameson JL; Jang Y
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1106-14. PubMed ID: 15541402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IGF-I receptor in cell growth, transformation and apoptosis.
    Baserga R; Hongo A; Rubini M; Prisco M; Valentinis B
    Biochim Biophys Acta; 1997 Jun; 1332(3):F105-26. PubMed ID: 9196021
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers.
    Jiang GL; Huang S
    Cancer Res; 2001 Mar; 61(5):1796-8. PubMed ID: 11280725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
    D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
    Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy.
    Adachi Y; Lee CT; Carbone DP
    Novartis Found Symp; 2004; 262():177-89; discussion 190-2, 265-8. PubMed ID: 15562829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The IGF-I receptor: a new antiproliferative marker?].
    Fehmann HC; Staats P; Göke B
    Z Gastroenterol; 1995 Oct; 33(10):630-1. PubMed ID: 7502562
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
    Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
    Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway.
    Lee YJ; Imsumran A; Park MY; Kwon SY; Yoon HI; Lee JH; Yoo CG; Kim YW; Han SK; Shim YS; Piao W; Yamamoto H; Adachi Y; Carbone DP; Lee CT
    Lung Cancer; 2007 Mar; 55(3):279-86. PubMed ID: 17134788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
    Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
    Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
    Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
    J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas.
    Wang JY; Del Valle L; Gordon J; Rubini M; Romano G; Croul S; Peruzzi F; Khalili K; Reiss K
    Oncogene; 2001 Jun; 20(29):3857-68. PubMed ID: 11439349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer.
    Werner H; Shalita-Chesner M; Abramovitch S; Idelman G; Shaharabani-Gargir L; Glaser T
    Mol Genet Metab; 2000; 71(1-2):315-20. PubMed ID: 11001824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
    Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.